0001237899-11-000030.txt : 20110405
0001237899-11-000030.hdr.sgml : 20110405
20110405164243
ACCESSION NUMBER: 0001237899-11-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110404
FILED AS OF DATE: 20110405
DATE AS OF CHANGE: 20110405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAHL NEIL
CENTRAL INDEX KEY: 0001226689
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 11740578
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0303
4
2011-04-04
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226689
STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Res and Dev Sciences
Common Stock
2011-04-04
4
M
0
92308
13
A
142658
D
Common Stock
2011-04-04
4
F
0
26356
45.53
D
116302
D
Common Stock
2011-04-04
4
F
0
31837
45.53
D
84465
D
Common Stock
2011-04-05
4
S
0
11200
45.83
D
73265
D
Common Stock
2011-04-05
4
S
0
22915
46.23
D
50350
D
Common Stock
5335
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
13
2011-04-04
4
M
0
92308
D
2013-12-15
Common Stock
92308
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
The reporting person sold 11,200 shares of Company stock on April 5, 2011 at prices ranging from $45.56 to $45.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 5, 2011 at each separate price.
The reporting person sold 22,915 shares of Company stock on April 5, 2011 at prices ranging from $46.00 to $46.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 5, 2011 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.
/s/**Neil Stahl
2011-04-05